⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8741732 | 0.73 | — | — | |
| SCHEMBL538399 | 0.65 | — | — | |
| SCHEMBL9422395 | 0.64 | — | — | |
| SCHEMBL5070284 | 0.59 | — | — | |
| SCHEMBL4434007 | 0.58 | — | — | |
| SCHEMBL535025 | 0.56 | — | — | |
| SCHEMBL11345853 | 0.56 | — | — | |
| SCHEMBL3657135 | 0.55 | — | — | |
| SCHEMBL3928670 | 0.55 | — | — | |
| SCHEMBL2618034 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2814921-A1 | MIXTURES OF OLEFIN-ESTER COPOLYMER WITH POLYOLEFIN AS VISCOSITY MODIFIER | The Lubrizol Corporation (US) | 2014-12-24 | — | — | EP | claimed |
| WO-2013123160-A1 | MIXTURES OF OLEFIN-ESTER COPOLYMER WITH POLYOLEFIN AS VISCOSITY MODIFIER | THE LUBRIZOL CORPORATION (US) | 2013-08-22 | — | — | WO | claimed |
| EP-2245117-B1 | BITUMINOUS COMPOSITIONS | CECA SA (FR) | 2012-04-25 | — | — | EP | claimed |
| EP-2093274-B1 | Bituminous compositions | CECA SA (FR) | 2011-07-27 | — | — | EP | claimed |
| EP-2678349-A1 | C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE | Taisho Pharmaceutical Co., Ltd. (JP) | 2014-01-01 | — | — | EP | disclosed |
| EP-2616441-A2 | PYRIDINE COMPOUNDS AND THE USES THEREOF | Purdue Pharma LP (US) | 2013-07-24 | — | — | EP | disclosed |
| WO-2012115256-A1 | C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-08-30 | — | — | WO | disclosed |
| WO-2012035421-A2 | PYRIDINE COMPOUNDS AND THE USES THEREOF | PURDUE PHARMA L.P. (US) | 2012-03-22 | — | — | WO | disclosed |
| EP-1427326-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | SUGEN INC (US) | 2005-06-08 | — | — | EP | disclosed |
| EP-1427326-A2 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | Sugen, Inc. (US) | 2004-06-16 | — | — | EP | disclosed |
| WO-2003015608-A2 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | SUGEN, INC. (US) | 2003-02-27 | — | — | WO | disclosed |
| WO-2002081466-A1 | PRODRUGS OF 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES | SUGEN, INC. (US) | 2002-10-17 | — | — | WO | disclosed |
| EP-0594596-A1 | COPOLYMERIZABLE IMIDAZOLIDINONE MONOMER | H.B. FULLER LICENSING & FINANCING, INC. (US) | 1994-05-04 | — | — | EP | disclosed |
| WO-1991012243-A2 | COPOLYMERIZABLE IMIDAZOLIDINONE MONOMER | H.B. FULLER LICENSING & FINANCING INC. (US) | 1991-08-22 | — | — | WO | disclosed |